Showing 2491-2500 of 6373 results for "".
Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-40/23808/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-43/23860/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-32/23672/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20594/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20393/The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?Agminated Pyogenic Granuloma: De Novo Presentations and Review of the Literature
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agminated-pyogenic-granuloma/23221/Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.